Scarica l'app Stockscreener
9.11
1.19%
-0.11
Dopo l'orario di chiusura:
9.11
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVDL Giù?
Forum
Previsione
Precedente Chiudi:
$9.22
Aprire:
$9.19
Volume 24 ore:
1.46M
Relative Volume:
1.29
Capitalizzazione di mercato:
$881.30M
Reddito:
$47.56M
Utile/perdita netta:
$-156.83M
Rapporto P/E:
-4.9781
EPS:
-1.83
Flusso di cassa netto:
$-127.98M
1 W Prestazione:
-0.22%
1M Prestazione:
+5.81%
6M Prestazione:
-17.63%
1 anno Prestazione:
-42.20%
Intervallo 1D:
$8.995
$9.20
Intervallo di 1 settimana:
$8.97
$9.31
Portata 52W:
$6.38
$17.30
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Nome
Avadel Pharmaceuticals Plc
Settore
Telefono
636-449-1830
Indirizzo
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Confronta AVDL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
9.11 | 883.23M | 47.56M | -156.83M | -127.98M | -1.83 |
|
HLN
Haleon Plc Adr
|
11.35 | 50.14B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
168.63 | 72.38B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.79 | 4.22M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 45.51B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.45B | 16.54B | -1.64B | 749.00M | -1.45 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-06-12 | Iniziato | Rodman & Renshaw | Buy |
| 2024-03-05 | Reiterato | H.C. Wainwright | Buy |
| 2024-03-05 | Reiterato | Needham | Buy |
| 2024-03-05 | Reiterato | Oppenheimer | Outperform |
| 2024-02-06 | Iniziato | UBS | Buy |
| 2022-11-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-08-10 | Downgrade | Jefferies | Buy → Hold |
| 2022-07-28 | Ripresa | Craig Hallum | Buy |
| 2022-05-26 | Downgrade | Stifel | Buy → Hold |
| 2021-09-23 | Iniziato | Needham | Buy |
| 2020-07-31 | Iniziato | Oppenheimer | Outperform |
| 2020-07-21 | Iniziato | SVB Leerink | Outperform |
| 2020-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2020-04-03 | Iniziato | Jefferies | Buy |
| 2020-03-12 | Iniziato | Stifel | Buy |
| 2020-02-26 | Iniziato | Piper Sandler | Overweight |
| 2020-01-30 | Iniziato | Craig Hallum | Buy |
| 2019-06-14 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
Mostra tutto
Avadel Pharmaceuticals Plc Borsa (AVDL) Ultime notizie
ProShare Advisors LLC Has $322,000 Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals plc (AVDL) Showcases LUMRYZ Success with 14 Abstracts, 4 Oral Presentations at SLEEP 2025 - Insider Monkey
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025 - The Manila Times
Wall Street Analysts Think Avadel (AVDL) Could Surge 97.68%: Read This Before Placing a Bet - Yahoo Finance
Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - TradingView
BNP Paribas Financial Markets Buys Shares of 23,292 Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $553,000 Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Ameriprise Financial Inc. Lowers Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Given Average Recommendation of “Buy” by Brokerages - Defense World
Cetera Investment Advisers Sells 24,747 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel wins appeal to expand LUMRYZ trials beyond narcolepsy By Investing.com - Investing.com Nigeria
Jazz Pharmaceuticals: One Step Forward, One Back (NASDAQ:JAZZ) - Seeking Alpha
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Bought by Northern Trust Corp - Defense World
Chesterfield pharmaceutical company adds C-suite role - The Business Journals
All You Need to Know About Avadel (AVDL) Rating Upgrade to Buy - Yahoo Finance
Avadel Pharmaceuticals: Moving Nicely Through An 'Inflection Year' (NASDAQ:AVDL) - Seeking Alpha
Price T Rowe Associates Inc. MD Acquires 6,445 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals appoints Susan Rodriguez as COO - MSN
AVDL Boosts Leadership with New COO Appointment | AVDL Stock News - GuruFocus
Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer - The Manila Times
Avadel appoints new COO to boost narcolepsy drug growth By Investing.com - Investing.com Canada
Avadel Pharmaceuticals Appoints New Chief Operating Officer - TipRanks
Avadel appoints new COO to boost narcolepsy drug growth - Investing.com
Avadel Pharmaceuticals Expands Leadership Team With Appointment Of Susan Rodriguez As Chief Operating Officer - marketscreener.com
Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference - The Manila Times
Earnings Estimates Moving Higher for Avadel (AVDL): Time to Buy? - Yahoo Finance
Wall Street Analysts Believe Avadel (AVDL) Could Rally 100.21%: Here's is How to Trade - Yahoo Finance
Leerink Partnrs Issues Positive Estimate for AVDL Earnings - Defense World
Equities Analysts Set Expectations for AVDL Q4 Earnings - Defense World
Analysts Are Updating Their Avadel Pharmaceuticals plc (NASDAQ:AVDL) Estimates After Its First-Quarter Results - Yahoo Finance
Needham & Company LLC Reaffirms “Buy” Rating for Avadel Pharmaceuticals (NASDAQ:AVDL) - Defense World
Avadel Pharma gains after appeals court ruling in Lumryz case with Jazz Pharma - MSN
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2025 Earnings Call Transcript - Insider Monkey
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up Following Strong Earnings - Defense World
First Trust Advisors LP Grows Stock Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
AVDL: Needham Reiterates Buy Rating with $19 Price Target | AVDL Stock News - GuruFocus
Avadel Pharmaceuticals Sees Strong Q1 Growth, Raises Guidance - TipRanks
Avadel: Q1 Earnings Snapshot - CT Insider
Transcript : Avadel Pharmaceuticals plc, Q1 2025 Earnings Call, May 07, 2025 - marketscreener.com
Appeals court reverses-in-part, vacates-in part ruling in Avadel-Jazz fight - Yahoo Finance
AVADEL PHARMACEUTICALS PLC SEC 10-Q Report - TradingView
Avadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises Guidance - The Manila Times
Avadel Pharma earnings beat, revenue fell short of estimates By Investing.com - Investing.com UK
Envestnet Asset Management Inc. Sells 32,618 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat
Avadel Pharmaceuticals (AVDL) Wins Court Victory for LUMRYZ Expa - GuruFocus
Avadel Pharmaceuticals (AVDL) Rises After Court Victory - GuruFocus
Federal Circuit Alters Avadel Pharmaceuticals (AVDL) Court Ruling | AVDL Stock News - GuruFocus
Avadel Pharmaceuticals Wins Court Ruling for LUMRYZ Expansion - TipRanks
Avadel Pharmaceuticals Announces Favorable Ruling In Appeal Of Delaware Court Injunction - marketscreener.com
Avadel Pharmaceuticals Plc Azioni (AVDL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
18.36%
0.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):